Angiotensin Ii Regulates Phosphoinositide 3 Kinase/Akt Cascade Via A Negative Crosstalk Between At(1) And At(2) Receptors In Skin Fibroblasts Of Human Hypertrophic Scars
Hong-Wei Liu,Biao Cheng,Wen-Lin Yu,Rui-Xia Sun,Dong Zeng,Jie Wang,Yuan-Xing Liao,Xiao-Bing Fu
DOI: https://doi.org/10.1016/j.lfs.2006.01.031
IF: 6.78
2006-01-01
Life Sciences
Abstract:Angiotensin II (Ang II) stimulation has been shown to regulate proliferation of skin fibroblasts and production of extracellular matrix, which are very important process in skin wound healing and scarring; however, the signaling pathways involved in this process, especially in humans, are less explored. In the present study, we used skin fibroblasts of human hypertrophic scar, which expressed both AT(1) ,and AT(2) receptors, and observed that Ang II increased Akt phosphorylation and phosphoinositide 3 kinase (PI 3-K) activity. In addition, the Ang II-induced Akt phosphorylation was blocked by wortmannin, a PI 3-K inhibitor. This Ang II-activated PI 3-K/Akt cascade was markedly inhibited by valsartan, an AT, receptor-specific blocker, whereas it was enhanced by PD123319, an AT, receptor antagonist. On the other hand. the Ang II- or EGF-induced activation of PI 3-K/Akt was strongly attenuated by AG 1478, an inhibitor of epidermal growth factor (EGF) receptor kinase. Moreover, Ang II stimulated tyrosine phosphorylation of EGF receptor and p85 alpha subunit of PI 3-K accompanied by an increase in their association, which was inhibited by valsartan, and enhanced by PD123319. The Ang II-induced transactivation of EGF receptor resulted in activation of extracellular signal-regulated kinase (ERK) that was also inhibited by valsartan, and enhanced by PD123319. Taken together, our results showed that AT, receptor-mediated activation of PI 3-K/Akt cascades occurs at least partially via the transactivation of EGF receptor, which is under a negative control by AT(2) receptor in hypertrophic scar fibroblasts. These findings contribute to understanding the molecular mechanism of human hypertrophic scar formation. (c) 2006 Elsevier Inc. All rights reserved.